Eurofins Scientific SE (ESF0) - Total Liabilities
Based on the latest financial reports, Eurofins Scientific SE (ESF0) has total liabilities worth €6.41 Billion EUR as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eurofins Scientific SE - Total Liabilities Trend (2016–2025)
This chart illustrates how Eurofins Scientific SE's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Eurofins Scientific SE Competitors by Total Liabilities
The table below lists competitors of Eurofins Scientific SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Petronas Chemicals Group Bhd
KLSE:5183
|
Malaysia | RM20.31 Billion |
|
AtkinsRealis Group Inc
TO:ATRL
|
Canada | CA$6.78 Billion |
|
Skanska AB (publ)
ST:SKA-B
|
Sweden | Skr96.34 Billion |
|
Dayforce Inc.
NYSE:DAY
|
USA | $5.98 Billion |
|
Aramark
LSE:0HHB
|
UK | $10.31 Billion |
|
WISE PLC LS -01
F:6WS
|
Germany | €17.86 Billion |
|
Ruijie Networks Co. Ltd. A
SHE:301165
|
China | CN¥4.43 Billion |
|
Service Corporation International
NYSE:SCI
|
USA | $17.02 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Eurofins Scientific SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurofins Scientific SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurofins Scientific SE (2016–2025)
The table below shows the annual total liabilities of Eurofins Scientific SE from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €6.41 Billion | +16.45% |
| 2024-12-31 | €5.50 Billion | -4.31% |
| 2023-12-31 | €5.75 Billion | +9.91% |
| 2022-12-31 | €5.23 Billion | +12.40% |
| 2021-12-31 | €4.66 Billion | -4.20% |
| 2020-12-31 | €4.86 Billion | -1.34% |
| 2019-12-31 | €4.92 Billion | +9.85% |
| 2018-12-31 | €4.48 Billion | +33.82% |
| 2017-12-31 | €3.35 Billion | +41.20% |
| 2016-12-31 | €2.37 Billion | -- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more